Dupixent (dupilumab) - Sanofi, Regeneron
Lung Function Improvement With Dupilumab In Severe Type 2 Asthma (ACAAI 2026) - Oct 28, 2026 - Abstract #R159; Pres time: Nov 14, 2026; 12:15 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 17; No abstract available 
Asthma • Immunology • Respiratory Diseases
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next